The U.S. Food and Drug Administration has an active solicitation for Implantable Medical-Grade Primary Lithium Batteries under 75F40126Q00420. The controlling SAM.gov notice was updated September 10, 2026 and extends the response deadline to September 15, 2026 at 12:00 PM EDT.
Maryland Opportunity Snapshot
- Issuer: U.S. Department of Health and Human Services, Food and Drug Administration, FDA Office of Acquisition and Grant Services.
- Solicitation: 75F40126Q00420.
- Status: Active solicitation, updated September 10, 2026.
- Deadline: September 15, 2026 at 12:00 PM EDT.
- Place of performance: Silver Spring, Maryland 20993.
- NAICS: 335910, Battery Manufacturing.
- PSC: 6135, Batteries, Nonrechargeable.
- Set-aside: None published.
- Funding/value: No authoritative contract ceiling or guaranteed procurement value is published in the current SAM.gov notice.
- Match/cost share: Not applicable; this is a procurement rather than a grant.
Scope
The contractor must furnish twenty new and unused implantable medical-grade primary lithium batteries using Li/SVO-CFx chemistry in two configurations of ten units each. No manufacturer, brand, model or manufacturer part number is specified, so an offered product must instead meet every published salient characteristic.
The high-rate configuration has detailed capacity, voltage, pulse-discharge, stainless-steel-case, sealing, dimensional and temperature requirements. The solicitation package also specifies a medium-rate configuration. All units within each configuration must satisfy the lot, product-documentation, safety, packaging, marking and delivery requirements in the controlling solicitation documents.
Vendor and Delivery Requirements
The current notice requires applicable commercial packaging and compliance with relevant lithium-battery transportation rules, including DOT and IATA requirements, plus advance shipping notification and coordination with the Government point of contact. Offerors should use the live solicitation and its attachments to establish exact technical acceptability, quotation content, delivery obligations and submission mechanics.
Posted Solicitation Package
The live SAM.gov notice identifies three public files: the solicitation document, the detailed lithium-battery requirements document and the vendor-response spreadsheet. The September 10 update changed the response deadline from the earlier date to September 15, 2026 at noon EDT.
Contact
The primary SAM.gov contact is Reagan Davis, reagan.davis@fda.hhs.gov, 301-796-0910. Prospective vendors should follow the controlling solicitation document for the exact response-delivery instructions rather than infer a submission route from the contact listing alone.
Atlas Fit Assessment
- Atlas Opportunity Score: 88/100.
- Nonagon N9+ Fit: 0/100. The requirement is for specialized primary lithium batteries; N9+ is not a legitimate fit.
- Dr. Miltie / QC Healthcare direct-vendor fit: 5/100 conditional.
- Direct-vendor determination: NOT CLEARED / No Bid based on currently verified records. Atlas has not verified compliant battery supply, exact specification compliance, required lot and shelf-life conditions, active vendor registrations, pricing, warranty or delivery capability for Dr. Miltie.
Controlling Source
SAM.gov – 75F40126Q00420. Verified September 12, 2026. The live SAM.gov notice and attachments control over summaries and should be rechecked for amendments before any response.